Cargando…
Efficacy and Safety of Huashi Baidu Granules in Treating Patients with SARS-CoV-2 Omicron Variant: A Single-Center Retrospective Cohort Study
OBJECTIVE: To evaluate the efficacy and safety of Huashi Baidu Granules (HSBD) in treating patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant. METHODS: A single-center retrospective cohort study was conducted during COVID-19 Omicron epidemic in the Mobile Cabi...
Autores principales: | Chen, Cai-yu, Zhang, Wen, Xu, Xiang-ru, Pu, Yu-ting, Tu, Ya-dan, Peng, Wei, Yao, Xuan, Zhou, Shuang, Fang, Bang-jiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206345/ https://www.ncbi.nlm.nih.gov/pubmed/37222827 http://dx.doi.org/10.1007/s11655-023-3549-8 |
Ejemplares similares
-
Huashi baidu granule in the treatment of pediatric patients with mild coronavirus disease 2019: A single-center, open-label, parallel-group randomized controlled clinical trial
por: Chen, Jiande, et al.
Publicado: (2023) -
Effectiveness and Safety of Baidu Jieduan Granules for COVID-19: A Retrospective Observational Multicenter Study
por: Xu, Xiang-ru, et al.
Publicado: (2022) -
Analyzing the potential therapeutic mechanism of Huashi Baidu Decoction on severe COVID-19 through integrating network pharmacological methods
por: Zhu, Yi-Wei, et al.
Publicado: (2021) -
Chemical profiling of Huashi Baidu prescription, an effective anti-COVID-19 TCM formula, by UPLC-Q-TOF/MS
por: WEI, Wen-Long, et al.
Publicado: (2021) -
Bioactive compounds from Huashi Baidu decoction possess both antiviral and anti-inflammatory effects against COVID-19
por: Xu, Haiyu, et al.
Publicado: (2023)